Efficacy and Feasibility of Combined Treatment for Neurodermatitis
Objective
To assess the effectiveness and practicality of using compound fluocinolone acetonide cream and guaiazulene in treating neurodermatitis.
Methods
A study was conducted on 92 neurodermatitis patients, dividing them into control and experimental groups. The control group received compound fluocinolone acetonide cream, while the experimental group also took oral guaiazulene tablets. Various parameters were monitored and compared between the two groups.
Results
The experimental group showed significant improvement in skin symptoms and signs, with lower scores compared to the control group. They also experienced reduced pain and itching, faster treatment onset, and improved quality of life.
Conclusion
Combining compound fluocinolone acetonide cream and guaiazulene demonstrates excellent efficacy and feasibility in managing neurodermatitis, offering superior clinical outcomes compared to standard treatment alone.
Practical Solutions and Value
Clinical trials are essential for developing safe treatments, and our AI-driven platform, DocSym, consolidates clinical standards and research for easy access by clinicians. Our mobile apps support scheduling, treatment monitoring, and telemedicine, streamlining operations and improving patient care. By leveraging AI, clinics can enhance workflows and improve patient outcomes, reducing paper routines.
Learn more about our solutions at aidevmd.com.
